SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-101535
Filing Date
2024-09-20
Accepted
2024-09-20 08:15:20
Documents
15
Period of Report
2024-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2424405d1_8k.htm   iXBRL 8-K 23726
2 EXHIBIT 99.1 tm2424405d1_ex99-1.htm EX-99.1 32907
6 GRAPHIC tm2424405d1_ex99-1img001.jpg GRAPHIC 4166
  Complete submission text file 0001104659-24-101535.txt   245938

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrns-20240920.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20240920_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20240920_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2424405d1_8k_htm.xml XML 3821
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241311731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)